UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria

Hepato-Gastroenterology

Volumn 57, Issue 101, 2010, Pages 819-825

  Ju, Man Ki ^a   Choi, Gi Hong ^a   Huh, Kyu Ha ^a   Joo, Dong Jin ^a   Kim, Soo Jin ^a   Choi, Jinsub ^a   Kim, Myoung Soo ^a   Kim, Soon Il ^a   Kim, Yu Seun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Pre transplant radiologic study; UCSF criteria

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; DOXORUBICIN; IODINATED POPPYSEED OIL;

ADRENAL METASTASIS; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMOEMBOLIZATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PATIENT SELECTION; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOLOGY; SURVIVAL RATE; TUMOR VOLUME; VALIDITY;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT SELECTION; PREOPERATIVE PERIOD; QUADRICEPS MUSCLE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78149264546     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lilvet JM, Beaugrand M: Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38(suppl):136-149.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al: Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona 2000 EASL Conference. J Hepatol 2001; 35:421-430.
3. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, et al: Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10:911-918. (Pubitemid 38979263)
4. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al: Recurrence of hepatocellular carcinoma after liver transplantation: Patterns and prognosis. Liver Transpl 2004; 10:534-540.
5. Todo S, Furukawa H: Living donor liver transplantation for adults recipients with hepatocellular carcinoma: Experience in Japan. Ann Surg 2004; 240:451-461.
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al: Liver transplantation for the treatment of small hepatocellular in recipients with cirrhosis. N Engl J Med 1996; 334:693-696.
7. Sauer P, Kraus TW, Schemmer P, Mehrabi A, Stremmel W, Buechler MW, et al: Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria? Transplantation. 2005; 80 (suppl):105-108.
8. Freeman RB: Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transpl. 2006; 12(suppl):8-13.
9. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394-1403.
10. Haberal M, Emiroglu R, Karakayali H, Moray G, Yilmaz U, Ozçay F, et al: Expanded criteria for hepatocellular carcinoma and liver transplantation. Int Surg. 2007; 92:110-115.
11. Karakayali H, Moray G, Sozen H, Dalgic A, Emiroglu R, Haberal M: Expanded criteria for liver transplantation in recipients with hepatocellular carcinoma. Transplant Proc. 2006; 38:575-578.
12. UNOS/POPTN policy 3,6.4.4. Available at http://www.optn.org. Accessed December 2007.
13. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7:462-503.
14. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, et al: Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004; 10:1343-1354. (Pubitemid 39530049)
15. O Nicholas, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB: Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the international registry of hepatic tumors in liver transplantation. Liver Transpl 2007; 13:391-399
16. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al: Liver transplantation criteria for hepatocellular carcinoma should be expanded. A 22-year experience with 467 patients at UCLA. Ann Surg 2007; 246:502-511.
17. Malagó M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, et al: Liver transplantation for hepatocellular carcinoma in cirrhosis: Is clinical tumor classification before transplantation realistic? Transplantation 2005; 79:483-487.
18. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, et al: Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation. 2006; 81:1633-1639.
19. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al: Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and expiant study. Transplantation 2006; 81:1532-1541.
20. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J of Transplant 2007; 7:2587-2596.
21. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, et al: Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006; 12:1761-1769.